<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P10194451A0000 Because of the probable causal relationship between constitutive p210(bcr/abl) protein tyrosine kinase activity and manifestations of chronic-phase chronic myelogenous leukemia (CML; myeloid expansion), a key goal is to identify relevant p210 substrates in primary chronic-phase CML hematopoietic progenitor cells."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="329" language="x-unspecified"/><edu.cmu.tanl.type.gene _indexed="1" _id="13" _ref_sofa="1" begin="57" end="60" Gene="p210"/><edu.cmu.tanl.type.gene _indexed="1" _id="18" _ref_sofa="1" begin="62" end="64" Gene="bcr"/><edu.cmu.tanl.type.gene _indexed="1" _id="23" _ref_sofa="1" begin="66" end="68" Gene="abl"/><edu.cmu.tanl.type.gene _indexed="1" _id="28" _ref_sofa="1" begin="77" end="90" Gene="tyrosine kinase"/><edu.cmu.tanl.type.gene _indexed="1" _id="33" _ref_sofa="1" begin="208" end="211" Gene="p210"/></CAS>